{Reference Type}: Case Reports
{Title}: A case of reversible toxic optic neuropathy from tacrolimus (FK506).
{Author}: Gokoffski KK;Patel VR;
{Journal}: Am J Ophthalmol Case Rep
{Volume}: 20
{Issue}: 0
{Year}: Dec 2020
暂无{DOI}: 10.1016/j.ajoc.2020.100932
{Abstract}: <B>UNASSIGNED: </B>To report a rare case of reversible vision loss from tacrolimus-associated toxic optic neuropathy.<BR><B>UNASSIGNED: </B>A 30-year-old man with cystic fibrosis requiring bilateral lung transplantation developed painless, bilateral, gradual onset central vision loss with dyschromatopsia two years after starting tacrolimus. Visual fields revealed bilateral cecocentral scotomas. Fundoscopy demonstrated bilateral temporal pallor of the optic nerves. Testing for nutritional deficiencies was unremarkable. Tacrolimus was switched to cyclosporine and the patient was started on idebenone. Two months later, the patient demonstrated marked improvement in his visual acuity and dyschromatopsia.<BR><B>UNASSIGNED: </B>Neurotoxicity is a rare but major potential side effect of tacrolimus. Idebenone should be considered as a potential, low-risk supplement for transplant patients who are immunosuppressed in whom toxic optic neuropathy is a concern.